Xenetic Biosciences, Inc. (XBIOW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.69M |
| Enterprise Value | -4.19M |
| P/E Ratio | -1.88 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 1.57 |
| Price/Book Ratio | 0.85 |
| Enterprise/Revenue | -0.41 |
| Enterprise/EBITDA | 0.54 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.76 |
| Operating Margin | -0.81 |
AD
Management Effectiveness
| Return On Assets | -0.36 |
| Return On Equity | -0.41 |
Income Statement
| Revenue | 2.98M |
| Revenue/Share | 1.42 |
| Gross Profit | 2.98M |
| EBITDA | -2.68M |
| Net Income | -2.68M |
| Diluted EPS | -1.58 |
Balance Sheet
| Total Cash | 6.47M |
| Total Cash/Share | 2.82 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.43 |
| Book Value Per Share | 2.65 |
Price History
| 52-Week Change | 69.63 |
| 52-Week High | 20.5 |
| 52-Week Low | 1.02 |
| Moving Average 50 Days | 12.44 |
| Moving Average 200 Days | 9.05 |
Statistics
| Average Volume | 635 |
| Shares Outstanding | 320,693 |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
